A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. [electronic resource]
Producer: 20140108Description: 3068-77 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Gene Rearrangement
- Genotype
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- Receptor Protein-Tyrosine Kinases -- genetics
- Treatment Outcome
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.